The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology

Novel genetic risk markers have helped us to advance the field of cardiovascular epidemiology and refine our current understanding and risk stratification paradigms. The discovery and analysis of variants can help us to tailor prognostication and management. However, populations underrepresented in...

Full description

Bibliographic Details
Main Authors: Elias Chappell, Laura Arbour, Zachary Laksman
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/11/2/56
_version_ 1797297900411158528
author Elias Chappell
Laura Arbour
Zachary Laksman
author_facet Elias Chappell
Laura Arbour
Zachary Laksman
author_sort Elias Chappell
collection DOAJ
description Novel genetic risk markers have helped us to advance the field of cardiovascular epidemiology and refine our current understanding and risk stratification paradigms. The discovery and analysis of variants can help us to tailor prognostication and management. However, populations underrepresented in cardiovascular epidemiology and cardiogenetics research may experience inequities in care if prediction tools are not applicable to them clinically. Therefore, the purpose of this article is to outline the barriers that underrepresented populations can face in participating in genetics research, to describe the current efforts to diversify cardiogenetics research, and to outline strategies that researchers in cardiovascular epidemiology can implement to include underrepresented populations. Mistrust, a lack of diverse research teams, the improper use of sensitive biodata, and the constraints of genetic analyses are all barriers for including diverse populations in genetics studies. The current work is beginning to address the paucity of ethnically diverse genetics research and has already begun to shed light on the potential benefits of including underrepresented and diverse populations. Reducing barriers for individuals, utilizing community-driven research processes, adopting novel recruitment strategies, and pushing for organizational support for diverse genetics research are key steps that clinicians and researchers can take to develop equitable risk stratification tools and improve patient care.
first_indexed 2024-03-07T22:28:01Z
format Article
id doaj.art-d584b8bd2f534889a277b95462e8ce7f
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-07T22:28:01Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-d584b8bd2f534889a277b95462e8ce7f2024-02-23T15:21:44ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252024-02-011125610.3390/jcdd11020056The Inclusion of Underrepresented Populations in Cardiovascular Genetics and EpidemiologyElias Chappell0Laura Arbour1Zachary Laksman2Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, CanadaDepartment of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, CanadaDepartment of Medicine and the School of Biomedical Engineering, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC V6T 1Z4, CanadaNovel genetic risk markers have helped us to advance the field of cardiovascular epidemiology and refine our current understanding and risk stratification paradigms. The discovery and analysis of variants can help us to tailor prognostication and management. However, populations underrepresented in cardiovascular epidemiology and cardiogenetics research may experience inequities in care if prediction tools are not applicable to them clinically. Therefore, the purpose of this article is to outline the barriers that underrepresented populations can face in participating in genetics research, to describe the current efforts to diversify cardiogenetics research, and to outline strategies that researchers in cardiovascular epidemiology can implement to include underrepresented populations. Mistrust, a lack of diverse research teams, the improper use of sensitive biodata, and the constraints of genetic analyses are all barriers for including diverse populations in genetics studies. The current work is beginning to address the paucity of ethnically diverse genetics research and has already begun to shed light on the potential benefits of including underrepresented and diverse populations. Reducing barriers for individuals, utilizing community-driven research processes, adopting novel recruitment strategies, and pushing for organizational support for diverse genetics research are key steps that clinicians and researchers can take to develop equitable risk stratification tools and improve patient care.https://www.mdpi.com/2308-3425/11/2/56cardiovascular epidemiologycardiogeneticsunderrepresented populationsdiversitygeneticsgenomics
spellingShingle Elias Chappell
Laura Arbour
Zachary Laksman
The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology
Journal of Cardiovascular Development and Disease
cardiovascular epidemiology
cardiogenetics
underrepresented populations
diversity
genetics
genomics
title The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology
title_full The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology
title_fullStr The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology
title_full_unstemmed The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology
title_short The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology
title_sort inclusion of underrepresented populations in cardiovascular genetics and epidemiology
topic cardiovascular epidemiology
cardiogenetics
underrepresented populations
diversity
genetics
genomics
url https://www.mdpi.com/2308-3425/11/2/56
work_keys_str_mv AT eliaschappell theinclusionofunderrepresentedpopulationsincardiovasculargeneticsandepidemiology
AT lauraarbour theinclusionofunderrepresentedpopulationsincardiovasculargeneticsandepidemiology
AT zacharylaksman theinclusionofunderrepresentedpopulationsincardiovasculargeneticsandepidemiology
AT eliaschappell inclusionofunderrepresentedpopulationsincardiovasculargeneticsandepidemiology
AT lauraarbour inclusionofunderrepresentedpopulationsincardiovasculargeneticsandepidemiology
AT zacharylaksman inclusionofunderrepresentedpopulationsincardiovasculargeneticsandepidemiology